Kite Pharma Inc. buy melinda
Start price
31.08.17
/
50%
€160.57
Target price
05.10.17
€166.87
Performance (%)
0.99%
End price
05.10.17
€162.17
Summary
This prediction ended on 05.10.17 with a price of €162.17. During the runtime of the prediction for Kite Pharma Inc. the price only changed by 0.99%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kite Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % | 58,55 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % | 80,51 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % | 62,78 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % | 54,39 % |
Comments by melinda for this prediction
In the thread Kite Pharma Inc. diskutieren
pharma
Kite Pharma, Inc.KITECéloleucel von Axicabtagène (KTE-C19) (BLA) bei der FDA Entscheidung über die KTE-C19 für Non-Hodgkin-Lymphom 2017.11.29
(Vom Mitglied beendet)